Literature DB >> 8858048

Molecular genetic basis of familial ALS.

T Siddique1, D Nijhawan, A Hentati.   

Abstract

Familial amytrophic lateral sclerosis (FALS) is transmitted in a mendelian fashion as an autosomal dominant (DFALS) or an autosomal recessive (RFALS) trait. Both DFALS and RFALS are genetically heterogeneous. Fifteen percent of DFALS families have mutations in the gene for Cu, Zn superoxide dismutase (SOD1) which is coded on chromosome 21. The locus for one form of RFALS maps to chromosome 2q33. Forty-six mutations in the SOD1 gene have been reported in DFALS families. These mutations result in decreased SOD1 activity and shortened half-life of the protein in most instances. Transgenic mice overexpressing mutated SOD1 protein develop an ALS-like disease which suggests that the degeneration of motor neurons in DFALS is caused by the gain of a novel toxic function by mutated SOD1 rather than by the decrease of SOD1 activity. Several possible mechanisms of the novel neurotoxic function of mutated SOD1 are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858048     DOI: 10.1212/wnl.47.4_suppl_2.27s

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  A possible therapeutic target for Lou Gehrig's disease.

Authors:  Soumya S Ray; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

3.  The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Sagar D Khare; Michael Caplow; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-08       Impact factor: 11.205

4.  The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families.

Authors:  Malessa Rabe; Ansgar Felbecker; Stefan Waibel; Peter Steinbach; Pia Winter; Ulrich Müller; Albert C Ludolph
Journal:  J Neurol       Date:  2010-03-23       Impact factor: 4.849

5.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant.

Authors:  L I Bruijn; M F Beal; M W Becher; J B Schulz; P C Wong; D L Price; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Amyotrophic lateral sclerosis: clinical management and research update.

Authors:  Jinsy Andrews
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

7.  Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants.

Authors:  L B Corson; J J Strain; V C Culotta; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

9.  Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis.

Authors:  T Mutoh; G Sobue; T Hamano; M Kuriyama; M Hirayama; M Yamamoto; T Mitsuma
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

10.  Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

Authors:  M S Petrik; J M B Wilson; S C Grant; S J Blackband; R C Tabata; X Shan; C Krieger; C A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.